Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan 
HEXO Acknowledges Zenabis Group CCAA Filing
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022...
ObsEva Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and without hormonal add-back...
U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation
DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”),...
Stephen Bardin to Join atai Life Sciences as CFO Designate
Stephen Bardin will join as CFO Designate on June 27, 2022After a transition period, atai’s current CFO Greg Weaver will...
Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain
BASEL, Switzerland and NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE)...
The Ensign Group, Inc. Declares Quarterly Dividend of $0.055 Per Share
SAN JUAN CAPISTRANO, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of...
Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA
Submission supported by comprehensive analytical and clinical data from new Phase I bridging pharmacokinetics studyAdalimumab’s high-concentration 100 mg/mL formulation aims...
Cresemba® sales in Asia Pacific region trigger sales milestone payment to Basilea from Pfizer
Basel/Allschwil, Switzerland, June 17, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today that the sales of...
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson’s Disease due to Slow Recruitment Rate
COVID-19 related challenges negatively impacted patient recruitment Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 17, 2022 -...
EssilorLuxottica announces launch of share buyback program
EssilorLuxottica announces launch of share buyback program Charenton-le-Pont, France (17 June 2022 - 7:00 am) – EssilorLuxottica announces the launch...
ObsEva Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and without hormonal add-back...
Boosh Plant-Based Brands Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Bosh"...
Sonendo, Inc. Announces Executive Management Team Changes
General Counsel and Chief Technology Officer to Step Down in July 2022 LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a...
Kilo Health Launches a Digital Health Product Offering for Enterprise
VILNIUS, LITHUANIA / ACCESSWIRE / June 17, 2022 / Kilo Health, the leading digital health product provider, launches an offering...
Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
GENEVA, SWITZERLAND / ACCESSWIRE / June 17, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), announced today that it has...
1933 Industries Announces that all Motions Passed at the Annual General Meeting
VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / 1933 Industries Inc. (the "Company" or "1933Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis...
ATI and TechConnect Announce First Round of Medical Innovation Challenge Winners and Round Two $200K Prize Pool
AUSTIN, Texas, June 16, 2022 /PRNewswire/ -- Advanced Technology International (ATI) and TechConnect today announced five winners of the Medical...
Epic Announces Plan to Join TEFCA, Champion Next Step in Evolution Toward Universal Interoperability
Continuing its decades of interoperability leadership, Epic's community of nearly 2,000 hospitals and 45,000 clinics will have the ability to...
NYC HEALTH + HOSPITALS DEBUTS OBSTETRICS VIRTUAL REALITY TECHNOLOGY AS PART OF ITS ONGOING, COMPREHENSIVE MATERNAL HEALTH SIMULATION TRAININGS
Providers will hone their skills to earlier detect and successfully address life-threatening conditions that can present during labor The simulation...
Computer Tool Can Track Stroke Rehabilitation to Boost Recovery
NEW YORK, June 16, 2022 /PRNewswire/ -- A sensor-equipped computer program can accurately identify and count arm movements in people...